Stenotrophomonas maltophilia infections: Current status on first-line therapy and other treatment options

18 May 2026
0

Stenotrophomonas maltophilia infections: Current status on first-line therapy and other treatment options

Charoenlap N, Poomchuchit S, Mongkolsuk S, Vattanaviboon P

Acta Microbiol Immunol Hung. 2026. doi:10.1556/030.2026.02883

Tags

Share this

Related Posts

Sodium arsenite exposure impairs B cell proliferation and enhances vascular inflammation in Plasmodium berghei mouse model Suntararuks S, , Worasuttayangkurn L, Akanimanee J, Suriyo T, Nookabkaew S, ,Srisamut N, Visitnonthachai D, Watcharasit P, Satayavivad J. Environ Toxicol Pharm. 2019; 66: 7-13.

Recent Posts